http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010082216-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92205428e0fbc3b39a4bab31a94b5ada
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3300303dd64bd9953bbd3c78c885688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19663289a26dcd04dc62239d8c215510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0970a918347296bf8efafc64112a441e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf21c23ed499041d18a8e505096fa05c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-82
filingDate 2009-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3c7be6a80e859405add2cd0c97fcf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b94565ef788148aaa488e2476632e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6335d1a59940bf65b7e00aafc933da87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee5799535a0eb7d73921221d4a05c56
publicationDate 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010082216-A3
titleOfInvention Novel salts of sibutramine and their crystal forms
abstract The present invention relates to novel acid addition salt of Sibutramine, [1-(4- chlorophenyl)-N,N-dimethyl-a-(2-methylpropyl)-cyclobutane-ethanamine] Sibutramine Maleate and the processes for their preparation.The present invention further relates to novel polymorphic forms of Sibutramine Fumarate, which include an anhydrate (Form-I), dihydrate (Form-II) and an amorphousform.
priorityDate 2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080055765-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070081233-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9813034-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2098602-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68752463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229698119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229699239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11176916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68752464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229698117

Total number of triples: 37.